Group 1 - The core viewpoint of the articles highlights the efforts of Weifang City's Market Supervision Administration in Shandong Province to enhance drug safety governance and regulatory efficiency through innovative monitoring models and risk management strategies [1][2]. Group 2 - A comprehensive risk prevention system has been established, including a collaborative risk consultation mechanism at provincial, municipal, and county levels, identifying 44 risk points in drug and medical device sectors, and implementing closed-loop management [1]. - The administration has conducted 8 expert evaluation meetings to identify 222 risk hazards and reported 35,000 adverse reaction monitoring reports, leading to the first proactive recall of a medical device by a multinational company in the province [1]. - A "clean source" action was initiated in drug distribution, resulting in 123 special case investigations and the development of eight measures to ensure quality and safety responsibilities among medical device businesses [1]. Group 3 - Collaborative efforts with health, medical insurance, public security, and education departments have led to comprehensive regulatory inspections of 170 drug and medical device units and special checks on 93 retail drug units [2]. - The administration has improved the vaccine information sharing mechanism and conducted two rounds of comprehensive inspections of vaccine usage units to ensure vaccine quality and safety [2]. Group 4 - Digital empowerment has been emphasized to enhance smart regulatory capabilities, transitioning from manual to technical defenses through the establishment of a digital regulatory archive [2]. - The Weifang City "Three Medicines" data sharing center has developed a smart regulatory system for practicing pharmacists, which is currently in trial operation to improve regulatory efficiency [2]. - The real-name registration system for narcotic and psychotropic drugs has been optimized, covering 11,000 drug operating units, enabling real-time monitoring and automatic data collection [2].

Core Viewpoint - The E'min County Market Supervision Administration has launched a "Clearing Source" action to regulate drug business practices and enhance drug quality supervision, ensuring public safety in medication use [1][2] Group 1: Action Mechanisms - A "screening-correction-acceptance" mechanism has been established to ensure safety through a closed-loop management system, focusing on issues such as the sale of counterfeit drugs and illegal procurement [1] - The action has resulted in inspections of 77 drug business enterprises, issuance of 26 corrective notices, and investigation of 13 illegal cases [1] Group 2: Collaborative Efforts - A "clue sharing-joint law enforcement-criminal connection" mechanism has been created to improve the efficiency of case handling, involving collaboration with health, medical insurance, and public security departments [1] - Eight inspection actions have been conducted, with five instances of case processing information shared with relevant departments and five case clues transferred [1] Group 3: Future Plans - The E'min County Market Supervision Administration plans to continue strengthening daily supervision and special rectification efforts, maintaining a high-pressure regulatory stance against drug-related violations [2] - There will be an increased emphasis on public education to encourage community involvement in drug safety supervision, fostering a supportive atmosphere for drug safety governance [2]

Group 1 - The eighth Hongqiao International Economic Forum's sub-forum on "Global Drug Safety Governance and China's Drug Regulatory Innovation" was held at the National Exhibition and Convention Center in Shanghai on November 6 [2]